Physician profile
Thomas Johnson
NPI 1679510291
$434.26
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.07 · 2020: $75.18 · 2021: $27.66 · 2022: $155 · 2023: $51.38 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.31 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $99.10 | 2020-2022 | |
| Abiomed | $88.24 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.30 | 2024 | Fruzaqla |
| Boston Scientific Corporation | $32.12 | 2023 | |
| Alexion Pharmaceuticals, INC. | $31.63 | 2022 | |
| Leo Pharma INC. | $30.43 | 2024 | Adbry |
| Pfizer INC. | $29.51 | 2021-2024 | |
| Janssen Scientific Affairs, LLC | $26.60 | 2020 | |
| Allergan, INC. | $24.07 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Bioxcel Therapeutics, INC. | $19.26 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.